RoActemra (tocilizumab) is a medication used to treat autoimmune and inflammatory conditions by targeting the interleukin-6 (IL-6) receptor. It can be effective in treating rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis, and cytokine release syndrome. The medication is given as an infusion or injection, and dosing will depend on the specific condition being treated and the patient’s response. Side effects may occur, including upper respiratory infections, headache, and diarrhea, and potential risks should be discussed with a healthcare provider. Patients should be monitored for potential side effects and exposure to contagious illnesses while on this medication. Overall, it is a promising treatment option for autoimmune and inflammatory conditions that can lead to significant improvement in symptoms and quality of life.